Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma

2 3 月, 2026

One Min Read

12 Views

原文: https://finance.yahoo.com/news/nuvation-bio-inc-nuvb-amends-075659670.html

Last Update: 2 3 月, 2026

Written By

Other Articles

Previous

Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab

Next

Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept